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ABSTRACT  Although rare among the general population, bone malignancies have a high rate of 
incidence among children and adolescents and are associated with high mortality rates. Osteosar-
coma (also known as osteogenic sarcoma) is the most frequent primary cancer of bone and shows 
a high tendency to metastasize to the lung. Despite the frequent use of osteosarcoma-derived cell 
lines in basic biomechanical research and for the evaluation of cell responses to new biomaterials, 
the mechanical phenotype and the differences between osteosarcoma cells and related cell types, 
such as mesenchymal cells, osteoblasts and osteocytes, remain largely unknown. In the present 
review we summarize current knowledge of the biophysical and mechanical properties of the niche 
of primary osteosarcomas and of the malignant cells, and discuss the impact of these features on 
the progression of malignancy. 
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Introduction
Osteosarcoma is the most frequent malignant cancer of the 
skeleton and displays a bimodal age distribution with most cases 
being diagnosed during the second decade of their life and a second 
highest incidence peak in adults over 40 (Jo and Fletcher, 2014). A 
remarkable characteristic of this malignancy is its high tendency to 
metastasize in the lungs via hematogenous route. Approximately 
20% of patients exhibit radiologically detectable lung metastases 
at diagnosis and nearly all of them have microscopic lesions that 
become evident during the course of the disease (Ross et al., 
1999). Although the 5-year-survival rate of people with localized 
osteosarcoma has improved significantly over the last decades 
and is currently in the range of 60% to 80%, the prognosis for 
those displaying detectable secondary lesions at diagnosis is much 
worse, as their rate after 5 years of diagnosis is only 15 to 30% 
(Gorlick and Khanna, 2010; Mirabello et al., 2009).
A number of factors, including radiation, trauma, genetic predis-
position and rapid bone growth have been suggested as possible 
etiologic factors of osteosarcoma (Ottaviani and Jaffe, 2009), 
however the cause and cell-of-origin of these tumors still remains 
unclear. The presence of different histologic forms of osteosarcoma 
points to a cell type with potential for pluripotent differentiation. This, 
along with the high incidence of osteosarcoma in growing children 
and their anatomic location within the metaphysis of long bones, 
where mesenchymal stem cells (MSCs) reside, supports the role 
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of this population as ‘tumor initiating cell’ (Mutsaers and Walkley, 
2014). Nevertheless, there is evidence to suggest more committed 
pre-osteoblastic cells that retain some differentiation potential as 
the origin of osteosarcomas. For instance, gene alterations that 
are known to promote bone malignancies, such as mutations in the 
P53 and retinoblastoma (RB) genes (Gorlick and Khanna, 2010), 
result in higher tumor incidence when the genetically modified 
cells express osteoblastic markers, such as osterix-1 (OSX) or 
osteocalcin (OCN) (Mutsaers and Walkley, 2014).
During tumor development and progression cancer cells ac-
quire genetic and epigenetic modifications that render them more 
competent in the neoplastic microenvironment and are therefore 
transferred to subsequent cell generations (Martincorena et al., 
2017). As a result of this selective pressure, those features that 
favor cancer cell survival and expansion are selected and give rise 
to the so-called ‘malignant phenotype’. As these changes are to a 
great extent driven by the biomechanical constraints that cancer 
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cells withstand, the description of the biophysical properties of 
the malignant cells and their microenvironment offers a different 
insight into their capabilities and impact on neoplastic progression 
(Northcott et al., 2018).
The physical microenvironment of osteosarcoma
Most of the knowledge on the biophysical properties of the 
bone microenvironment has been derived from the development 
of implantable biomaterials. The biophysical properties of these 
implants, such as roughness, surface energy and stiffness, are 
among the most studied passive elements of the bone niche.
Rugosity
The impact of surface roughness (Ra) on cell attachment has been 
studied using various cell types, including osteosarcoma-derived 
cells. In the case of MG-63 osteosarcoma cells highest levels of 
adhesion were found in surfaces with an Ra value of 2.4 mm, being 
the attachment on smoother surfaces significantly reduced. The 
spreading area of osteosarcoma cells is also significantly affected 
by surface topography, with the cells on rough substrates being 
significantly smaller (Dowling et al., 2011). Interestingly, it has been 
reported that the reduction in projected area is more pronounced 
in primary osteoblasts, which decrease their surface by over 60% 
in substrates with an Ra of 6.07 mm compared to flat ones, than for 
MG-63 cells, for which the reduction represents only 20% (Lüthen 
et al., 2005). It has also been found that osteosarcoma cells that 
adhere to rough substrates upregulate their expression of a5, b1 
and particularly, b3 integrins, and increase their basal alkaline 
phosphatase (ALP) activity and OCN expression, whereas their 
proliferative potential is reduced (Lincks et al., 1998; Lüthen et 
al., 2005). 
Lohmann and colleagues (2000) compared the response of 
osteogenic cells to increasing differentiation on titanium surfaces 
with different rugosities and observed that the proliferation and 
expression of osteogenic markers of osteoblast-like cells and MSCs 
were less affected by surface texture than in the case of more 
mature osteocytes (Lohmann et al., 2000). In turn, MG-63 cells 
follow an intermediate program, in agreement with their moderate 
osteoblastic phenotype (Lincks et al., 1998; Martin et al., 1995). 
It should be noted that these observations are not limited to dif-
ferentiation and alterations in other pathways caused by substrate 
topography, such as sensibility to a number of exogenous factors, 
have also been reported (Boyan et al., 2001). It is also important 
to remember that cellular response to these surface-guided effects 
is strongly influenced by biological factors such as the ligands that 
are used to coat the surfaces prior to cell attachment. For instance, 
it was shown that when using calcium phosphate hydroxyapatite 
substrates, which have a similar composition as bones, MSCs 
preferentially attach to them when previously coated with collagen-I 
instead of fibronectin. However, osteosarcoma cell lines, such as 
SaOs-2 and MG-63 have the apposite tendency (Vohra et al., 2008). 
Among topography-driven cell behaviors, contact guidance 
refers to the likelihood of cultured cells to align along geometrical 
features such as grooves or fibers, and is a common characteristic 
of eukaryotic cells, including osteoblasts (Lenhert et al., 2005). 
The ‘orientation parameter’ (ainf) is an indication of the suscepti-
bility of cells to align along grooved substrates independently of 
the experimental conditions. For primary osteoblasts, this value 
is close to 0°, indicating complete alignment of the cells. On the 
other hand, the reported ainf value for osteosarcoma SaOs-2 
cells is 23°, which implies that these cells have partially lost their 
contact guidance feature (Davidson et al., 2015). However, when 
performing an orientation analysis of the nuclei of the same cells, 
it was observed that the nuclei of SaOs-2 display orientations 
similar to those of the cell body, even on non-patterned substrates, 
while in osteoblasts, this correlation does not exist in either case 
(Davidson et al., 2015). 
Wettability
Topography and chemical properties define the wettability of a 
surface, which can be expressed as the contact angle (θ) of a water 
droplet resting on it, and corresponding low values to hydrophobic 
and large ones to hydrophilic surfaces. It has been reported that 
SaOs-2 cells adhering to a surface with a θ of 44° display smaller 
spreading areas, lower proliferation, and higher ALP activity than 
when cultured on substrates with 84° and 34° water contact angles 
(Jirka et al., 2017). Although with slightly different θ values, MG-63 
cells respond similarly to surface wettability and attach preferentially 
to polystyrene surfaces with θ values of approximately 64° (Dowl-
ing et al., 2011). Interestingly, primary human MSCs that grow on 
stiff silicone substrates doped with poly (dimethylsiloxane-ethylene 
oxide) (PEO) surfactant and have a θ value in the same range 
(60°), display a tendency of osteogenic differentiation (Razafiari-
son et al., 2016). Although the regulatory mechanism is not fully 
understood, a plausible explanation is the hydrophobicity-driven 
exposure of cell binding sites in the deposited extracellular matrix 
(ECM), collagen I in this case, which in turn directs the expression 
of focal adhesion components (Razafiarison et al., 2018).
Stiffness
In general, tumor cells are known to cause the stiffening of the 
surrounding tissue due to an increased deposition of ECM pro-
teins and crosslinking of these through secreted factors (Lu et al., 
2012). As osteosarcomas arise in the hardest tissue of the body 
the dogma that states that solid tumors are macroscopically harder 
than the healthy tissue from which they originate does not apply 
in this case. By using osteosarcoma-affected canine antebrachia, 
it was shown that these tissues are markedly weaker and more 
compliant, exhibiting a step-by-step reduction in load after reaching 
maximum load, indicative of sequential structural failures (Steffey 
et al., 2017). A number of non-exclusive mechanisms have been 
described as cause of bone tissue softening. Firstly, as it happens 
in many tumor types, osteosarcoma cells are known to secrete 
enzymes that lead to the decomposition of the main components 
of the tissue (Bjørnland et al., 2005). On the other hand, the 
formation of distant metastases is associated with the presence 
of osteoclasts in the biopsies of the primary malignancy. These 
monocyte-derived cells are responsible for bone degradation in 
physiological conditions, and it has been shown that osteosarcoma 
cells can also regulate their activity by releasing soluble growth 
factors, including nuclear factor kappa-B ligand (RANKL), tumor 
necrosis factor-a (TNF-a) and interleukin-11 (IL-11) (Avnet et al., 
2008; Verrecchia and Rédini, 2018). Furthermore, osteosarcoma 
cells are known to regulate the production of factors, such as bone 
morphogenetic proteins (BMPs) or parathyroid hormone-related 
proteins (PTHrP), which drive the production of RANKL by osteo-
blasts, thereby increasing osteoclast activity. Furthermore, there is 
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evidence of the mechanoregulated secretion galectin-3, a member 
of the b-galactoside binding lectin family. While in adherent state 
cancer cells secrete low levels of galectin-3 into the medium, once 
the cells acquire rounded shapes, the concentration increases 
significantly (Baptiste et al., 2007). In addition to its impact in 
integrin clustering and activation, galectin-3 is considered a nega-
tive regulator of bone formation (Zhou et al., 2014; Iacobini et al., 
2017), and it is likely that high levels of galectin-3 exacerbate the 
softening of the tissue concomitant to osteosarcoma progression 
(Maupin et al., 2018).
As we will discuss later, the ability of cells to probe their mechani-
cal microenvironment depends on the generation and transmission 
of oscillating pulling forces through the actin cytoskeleton and 
adhesion complexes that connect the cytoskeleton to the ECM. It 
is known that changes in ECM stiffness provoke different degrees 
of cell spreading, which in turn determines the tension transmitted 
to the actin cytoskeleton. In this context, YAP (yes-associated pro-
tein) and TAZ (transcriptional co-activator with PDZ-binding motif), 
the main transcriptional effectors of the Hippo signaling pathway, 
are known to shuttle from the cytoplasm to the nucleus in cells 
adhering to stiff substrates and when the spreading area is limited 
(Dupont et al., 2011). Although the precise mechanism by which 
these transcription factors activate is not completely understood, it 
seems clear that cytoskeletal tension and GTPase Rho are needed 
for this purpose. The implications of this regulatory mechanism 
drive MSC differentiation towards cell lineages that reside in tissues 
that posses similar mechanical properties (Engler et al., 2006). For 
instance, MSCs adhering to soft surfaces tend to be neurogenic 
while, on stiffer substrates, they activate myogenic or osteogenic 
differentiation programs. The tissue in which cancer arises also 
defines the stiffness at which the so-called cancer stem cells (CSCs) 
propagate faster. For instance, while breast CSCs prefer gels dis-
playing a Young’s modulus (E) of 5 kPa, U2OS osteosarcoma cells 
proliferate and retain their stemness better when adhering to 50 
kPa gels (Jabbari et al., 2015). Similarly, Mylona and colleagues 
(2008) analyzed the effect of substrates with E values of 1, 7, and 
55 kPa on primary osteosarcoma cells and observed an increase 
in the number of apoptotic cells on soft substrates, with the sur-
vival rate of cells on 55 kPa polyacrylamide gels and glass (E>50 
GPa) being the highest (Mylona et al., 2008). In a similar study in 
which the response of MG-63 cells was compared with that of a 
neuroblastoma cell line on softer substrates with E values in the 
0.3 to 12 kPa range, it was revealed that, depending on surface 
rigidity, the phenotype of osteosarcoma cultures shifts between 
well-spread monolayers on substrates with an E modulus higher 
than that of the cells and multi-cell spheroid-like aggregates when 
growing on substrates with stiffness values below that threshold 
(Pak et al., 2015) (Fig. 1). However, neuroblastoma-derived cells 
did not exhibit the same behavior, and no equivalent phenotypic 
shift was observed (Pak et al., 2015).
Forces acting on bone resident cells
More than 30 years ago, Frost hypothesized the mechanical 
regulation of bone remodeling and named it ‘mechanostat’ (Frost, 
1987). According to this principle, depending on the magnitude, 
range, duration, and frequency of the load to which bone is exposed, 
different biological programs are triggered. While underloaded 
bones reduce their mass and strength, overload results in the 
reinforcement of the tissue, and under intermediate mechanical 
Fig. 1. Impact of substrate 
stiffness on osteosarcoma 
spreading and aggregation. 
(A) Independently of the cell 
adhesive motif used (Fibronectin 
or RGD peptide), U2OS cells form 
multicellular aggregates when 
cultured on soft substrates (0.5 
and 4.5 kPa) and display a spread 
morphology on stiffer ones (10 
and 40 kPa). (B) Similar phe-
notypic changes are observed 
in MG-63 cells adhering for 4 
days to hydrogelss of different 
stiffnesses coated with collagen 
I. Scale bar represents 100 mm.
B
A
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stress, bone mass and strength remain constant (Frost, 2003). 
Since this hypothesis was first proposed several biomechanical 
stimuli driving this adaptation have been discovered (Fig. 2). 
Shear stress
Although compressive forces are the most obvious stresses 
acting on bone, these are actually transmitted to osteocytes as 
microscale shear forces, which result from the movement of the 
interstitial fluid within the lacuno-canalicular network. Shortly after 
exposure to these shear forces, the cytoplasmic levels of calcium 
in the resident osteocytes increase, and these cells activate cel-
lular programs that potentiate bone formation and remodeling by 
stimulating the neighboring osteocytes and osteoblasts through 
gap-junctions and paracrine signaling (Wittkowske et al., 2016). 
The oscillatory nature of the flow profile experienced in their 
natural environment is known to affect these cells in a different 
manner than unidirectional shear stresses. For instance, it has 
been observed that after 24 hours under oscillatory flow regimes 
(11 dyn/cm2, 0.5 Hz), MLO-Y4 osteocytes display more elongated 
shapes, form numerous dendrites, and upregulate the expression 
of cyclooxygenase (COX), not existing such responses in cells 
under unidirectional shear regimes of similar magnitude (8 dyn/
cm2) (Ponik et al., 2007).
MC3T3-E1 osteoblasts have been reported to respond to fluid 
stress in the range of 12 dyn/cm2 by reorganizing their actin cyto-
skeleton into stress fibers and recruiting b1 integrin and a-actinin 
in the focal adhesions (Pavalko et al., 1998). These cytoskeletal 
changes seem to require a longer time to occur when osteoblasts 
are exposed to an oscillatory flow, being however the upregulation 
of COX and osteopontin (OPN) in both flow regimes, comparable 
(Ponik et al., 2007). Exposing normal human mandible-derived 
osteoblasts to shear stresses in the range of 20 dyn/cm2 for 30 
minutes causes their proliferation and differentiation through Erk1/2 
activation (Kapur et al., 2003). However, these experiments did not 
exclude the involvement of other pathways, particularly related to 
nitric oxide (NO) and prostaglandin production, with respect to the 
shear stress-response of osteoblasts. In fact, experiments using 
newborn rat calvarial osteoblasts revealed that fluid shear stress 
stimulates NO release through two distinct pathways, a G‐protein 
and calcium‐dependent phase, which is sensitive to flow tran-
sients, and a G‐protein and calcium‐independent pathway, which 
is stimulated by sustained flow (McAllister and Frangos, 1999). 
Compression
Osteocytes also respond to direct compressive stimuli. For in-
stance, the fully differentiated osteoblastic murine cell line MLO-A5 
cultured in 3D scaffolds upregulates the expression of OPN and 
OCN when exposed to a compressive loading regime consisting of 
5% strain at 1 Hz for 2 hours every 5 days over a total time span 
of approximately three weeks (Sittichockechaiwut et al., 2009). 
Although apparently less sensitive, osteoblasts embedded in 
collagen gels exposed to a static compression of 2 g/cm2 display 
a higher expression level of OCN along with upregulated levels 
of the osteogenic marker RUNX2 and increased secretion of os-
teoclastic differentiation factors (Shen et al., 2017). Regimes with 
higher load values do not further enhance the expression of these 
osteogenic markers (Shen et al., 2017) and may ultimately produce 
the opposite effect. Using a bioreactor that applies compressive 
load by increasing the pressure of environmental gas up to 3 atm 
(31 g/cm2), a significant reduction in ALP activity in osteoblasts 
was found. Furthermore, under these conditions, osteoblastic 
cells were shown to secrete paracrine factors that promote the 
undifferentiated state of neighboring cells (Ozawa et al., 1990). As 
undifferentiated tumors are more aggressive than those with a more 
mature phenotype, these observations suggest that the compres-
sive load that bone malignancies experience in their primary site 
and the overload caused in the surrounding healthy tissue could 
negatively impact their progression. To analyze the effect of such 
mechanical stimuli on malignant cells a group of researchers used 
decellularized bone and bioengineered gels to test the effect of 
Fig. 2. Biomechanics of pre-
malignant (left) and malignant 
(right) osteosarcoma cells 
and their microenvironment. 
Unlike soft tissue neoplasms, 
osteosarcoma lesions are more 
compliant than the tissue in 
which they originate. This unique 
feature together with the loss of 
tissue architecture over malig-
nant progression, provokes alter-
ations in the mechanical stimuli 
to which osteosarcoma cells are 
exposed, including altered compressive and tensile deformation profiles. In turn, osteosarcoma cells are less sensitive to the potential topographical 
changes accompanying tissue softening and, for instance, do not align their nucleus along elongated features, as non-transformed osteoblasts do. Ad-
ditionally, osteosarcoma cell malignancy correlates with reduced focal adhesion (FA) count, smaller contractility potential and softening of the cell cortex.
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compressive mechanical loading on Ewing’s sarcoma, the second 
form of bone cancer in terms of incidence (Marturano-Kruik et al., 
2015; Marturano-Kruik et al., 2018). Their results reveal that under 
physiological load regimes Ewing’s sarcoma cells rescue signaling 
pathways, including Erk1/2-Runx2 signaling, that promote tumor 
development and proliferation and confer chemoresistance to the 
cells. As many of these resistance pathways are shared among dif-
ferent tumor types, and considering the nearly identical stimuli that 
osteosarcoma cells experience in their primary site, this evidence 
should be considered while testing chemotherapeutic agents on 
this tumor type (Martin et al., 2011).
Tensile stress
Mechanical compression of bone is accompanied by elastic 
deformations, which cells sense as tensile strains. This mechanical 
stress is defined as E= L0/L, with L0 and L being the initial length and 
length under tension, respectively. The resulting value has no units 
and can be noted as a percentage deformation or as microstrain 
(mE), which is obtained by multiplying the change in length by 106. 
While in vivo, bone mass has been reported to increase when strains 
are larger than 0.15%, in vitro cells require larger deformations to 
activate their osteogenic program. A plausible explanation to this 
inconsistency is the underestimation of the physiological shear 
stresses occurring in the lacuno-canalicular network (Han et al., 
2004). In this regard, a number of mathematical models have pointed 
out the ability of the the osteocyte physical environment to amplify 
the strain. For instance, it has been estimated that in their native 
environment osteocytes exposed to strains in the range of 3000 
mE experience significantly higher deformations in their cell body 
with maximum values of over 20.000 mE (Verbruggen et al., 2012). 
Tensile stress is known to impact the differentiation of preosteo-
blasts through the BMP4-dependent activation of the Cbfa1/Osf-2 
transcription factor (Ikegame et al., 2001). However, as it was the 
case for shear stress, the effect of tensile stress on differentiation 
seems to be dramatically affected by its magnitude. For instance, 
an analysis of the response to strains in the range of 0.8 to 3.2% 
revealed that ALP activity is highest in the lower range, but it signifi-
cantly reduces for strains higher than 1.6%. Similarly, healthy human 
primary osteoblasts showed that a stretching protocol consisting 
of 1000 mE at 1 Hz for 1800 cycles for 2 days causes a significant 
increase in cell number, while ALP activity and osteocalcin release 
are reduced (Kaspar et al., 2000). More intense loading protocols 
(2500 mE at 0.5 Hz for 1 hour per day over a total timespan of 3 
days) cause a similar increase in osteoblast cell division along with 
an upregulation of the expression of b1 and b5 integrins (Yan et al., 
2012). siRNA experiments further revealed a link between these 
integrins and the upregulation of the Erk pathway (Yan et al., 2012). 
Regarding osteosarcoma, SaOs-2 cells biaxially loaded at an 
average deformation of 5% for 24 hours increase their expression 
of TGF-b1, IGF-1, bFGF, and IL-6, with the levels of IL-1B remain-
ing unaltered. This regulation can be interpreted as similar to that 
observed in osteoblasts, increasing the expression of bone growth 
factors, while leaving catabolic cytokine expression unaffected (Cillo 
et al., 2000). Similarly, ROS 17/2.8 rat osteosarcoma cells increase 
the activation of Erk-1/2, which is sustained for 24 hours, when 
subjected to a 10-minute period of cyclic tensile loading (Jessop 
et al., 2002). Further experiments in which the contribution of dif-
ferent pathways to this response pointed to calcium mobilization 
from intracellular stores and production of NO and prostacyclin 
(PGI2) as central to the activation of Erk-1 (Jessop et al., 2002), 
being these pathways different to those triggered by shear stress. 
The biomechanical phenotype of osteosarcoma cells
Force generation
The mechanism by which cells sense and respond to surface 
rigidity involves generation of oscillating pulling forces through cell-
substrate adhesions (Ghassemi et al., 2012). Methods to estimate 
these forces employ compliant substrates, such as polyacrylamide 
(PAA) gels or silicon-based surfaces, with fiducial markers, or flex-
ible micropillar arrays to which cells adhere and deflect, to estimate 
traction forces (Goedecke et al., 2015; Holenstein et al., 2017). By 
using these methods, it was shown that cells adapt the force they 
generate to the apparent stiffness of the underlying substrates. 
For instance, MG-63 cells on soft PAA gels (E= ~1 kPa) generate 
tractions below 0.5 kPa, whereas on 55 kPa gels, magnitudes of 
over 2 kPa were recorded (Mylona et al., 2008). It has been also 
reported that generated tractions correlate with differentiation state, 
being in case of undifferentiated MSCs the recorded mean values 
around 128 Pa, 200 Pa for MC3T3-E1 osteoblasts and over 350 Pa 
in case of the fully differentiated MLO-A5 osteocyte cell line when 
tested on 9.3 kPa PAA gels (Poellmann et al., 2015). With respect 
to malignant cells, a correlation between lower force generation 
capabilities and increased malignancy has been proposed for a 
number of tumor types, including breast, prostate and lung cancers 
(Kraning-Rush et al., 2012). Nevertheless, this trend seems to be 
the opposite in the case of osteosarcomas. In our laboratory, we 
used a semi-high-throughput method in which osteosarcoma cells 
attaching to silicone micropillar arrays were automatically imaged, 
and the deflections of the microposts quantified. The results showed 
that the experimentally selected highly metastatic HuO9-M132 
cells cover fewer posts and generate significantly smaller forces, 
being the average force on each post also smaller (Goedecke et 
al., 2015). This result was recently confirmed and was extended 
to the SaOs-2/LM5 paired osteosarcoma cells using standard two-
dimensional TFM and micropost-based TFM (Holenstein et al., 
under review). The results of this experiments point to a gradual 
reduction in force generation from healthy osteoblasts as they adopt 
a malignant phenotype. The relationship between the decreased 
cellular tractions and the simultaneous softening of the tissue as 
the neoplasm develops is not common to other tumor types and 
may be of relevance in this and other bone tumors. This unique 
feature may also explain the previously discussed aggregation of 
osteosarcoma cells growing on soft surfaces (Pak et al., 2015). 
Mechanical properties in the adhering state
The first attempt to mechanically characterize single osteo-
sarcoma-derived cells was reported 1999 as a newly developed 
cytoindenter was used to test MG-63 cells and their average 
Young’s modulus (E) was estimated to be nearly 2 kPa (Shin and 
Athanasiou, 1999). Since then, the use of atomic force microscopy 
(AFM) for the mechanical characterization of biological tissues 
and cells has gained popularity, and up to date many research 
groups have used it to estimate the stiffness of osteosarcoma 
cells. Depending on the cell line being tested and on the experi-
mental conditions, the obtained E values may vary between less 
than 1 and 4 kPa (Bartalena et al., 2011; Wang et al., 2016). As 
cell indentation measurements are highly affected by underlying 
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cytoplasmic structures such as the nucleus, organelles and stress 
fibers, this variability can be explained by the different cell regions 
tested in each study. For instance, probing U2OS osteosarcoma 
cells in the nuclear region (defined by the authors as parts of the 
cell higher than 1 mm) renders a mean elastic modulus of 2.8 
kPa, with the average stiffness of the peripheral region (< 1 mm) 
being 4.4 kPa with peak values of 7.5 kPa (Zhang et al., 2017). It 
should be noted that a significant softening of MG-63 cells during 
the telophase stage of the cell cycle has also been documented 
(Zhang et al., 2017), which exposes the importance of considering 
biological processes during the experimental design of studies on 
single cell mechanics. With respect to healthy bone cells in adher-
ing state, Darling and colleagues (2008) reported an E value of 
6.5 kPa for the central region of osteoblasts and 3.2 kPa for MSCs 
(Darling et al., 2008), suggesting cell body stiffening as a marker 
of osteoblastic differentiation. However, other authors found the 
opposite trend, depending again on the experimental conditions 
(Bongiorno et al., 2014). For instance, while human osteoblasts 
and osteosarcoma-derived MG-63 cells both display a E value of 
approximately 1.5 kPa when cultured on bare glass, on collagen 
I-coated surfaces the stiffness of the tumorigenic cells drops by 
nearly 50% remaining in case of osteoblasts unaltered (Docheva 
et al., 2008).
As previously mentioned, microindentation is highly affected by 
the mechanical properties of the nucleus. The biophysical proper-
ties of this organelle are conferred by a filamentous protein layer 
that lies beneath the nuclear envelope and has as main constituent 
lamin A/C. It is known that the amount of lamin A present in these 
networks increases with the stiffness of the tissue where cells are 
found, being in case of MSCs and bone cells highest (Swift et al., 
2013). As previously discussed, an increased tendency to deform 
their nucleus and elongate it along the cell body axis was observed 
in SaOs-2 osteosarcoma cells over healthy osteoblasts (Davidson 
et al., 2015). In fact, when adhering to micropatterned surfaces 
containing micron-sized pillars at distances smaller than the size 
of the nucleus, all tested osteosarcoma cell lines, including MG-63, 
SaOs-2, and OHS4, display higher nuclear self-induced deforma-
tions than normal osteoblasts (Davidson et al., 2015). Apart from 
the potential use of this experimental approach in combination 
with automatic imaging and segmentation, for the estimation of cell 
malignancy (Ermis et al., 2016), the reduction in nuclear stiffness 
has also significant impact in the capabilities of cancer cells. For 
instance, it is known that in a number of cancer types, cell body 
and nuclear deformation act as factors that limit the invasion of 
stiff matrices (Chen et al., 2018). 
Mechanical properties in the free-floating state
During their hematogenous metastatic dissemination, cancer 
cells adopt rounded shapes and are carried by the blood circulation. 
In this stage of cancer progression, the major biomechanical threats 
cancer cells have to overcome are shear stress and collision forces. 
Under these circumstances, the cell cortex, a network of proteins 
attached to the cytoplasmic side of the plasma membrane through 
anchoring proteins, acquires central importance in determining 
the biomechanical properties of the cell. The main component of 
the cortex is actin, which appears forming filaments crosslinked to 
each other by myosin II and other actin-binding proteins. Although 
the properties of rounded cells can be determined using AFM, 
the use of this tool renders a low throughput and high variability. 
In turn, real time deformability cytometry (RT-DC) is a method 
for the characterization of non-adhering cells that makes use of 
microfluidics and high speed imaging to assess the mechanical 
phenotype of large cell populations (Otto et al., 2015). In a recent 
article, which made use of this tool, the deformability of skeletal 
stem cells (SSCs), an MSC population characterized by STRO-1 
expression, and that of MG-63 osteosarcoma cells was shown to 
be similar (Xavier et al., 2016). However, when unselected MSCs 
populations were tested using the same technique, MSCs were 
found to be stiffer than both, osteosarcoma-derived cells and SSCs. 
In addition, a trend of increased deformability of experimentally 
selected highly metastatic osteosarcoma cells has as well been 
described recently (Holenstein et al., under review), pointing to 
changes in this mechanical property as a potential diagnostic and 
prognostic marker of circulating tumor cells in peripheral blood of 
osteosarcoma patients, as it has been proposed for other tumor 
types (Wu et al., 2016). 
Conclusions
Although frequently used in basic biomechanical research and 
in the testing of implantable biomaterials as a model for bone 
cells, the biomechanical properties of osteosarcoma cells have 
rarely been compared with those of related cell types, such as 
osteoblasts or MSCs. Similarly, the comparison between the 
mechanical profile of healthy tissue and primary malignancy, as 
done for other neoplasms, is missing in the case of bone tumors. 
Therefore, drawing definitive conclusions about many of the aspects 
that have been discussed in this review is not possible. However, 
some biomechanical parameters follow a trend in independent 
studies or have been subject to comparative analysis, allowing us 
to outline the biomechanical malignant phenotype of these cells. 
For instance a gradual loss of the ability to sense environmental 
stiffness, as evidenced by a reduced response to surface rough-
ness and lower force generations, seems to be associated with 
osteosarcoma malignancy. Additionally, cell body softening in 
free-floating state is characteristic of malignant transformation and 
of increased metastatic potential. As such cellular features affect 
the sensibility of bonce cancer cells to chemotherapeutic drugs 
these observations should be considered when testing treatment 
options in vitro. 
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